Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04088188
Title Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United



Cisplatin + Gemcitabine + Pemigatinib

Cisplatin + Gemcitabine + Ivosidenib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST